American BioMed receives patent notice of allowance for guidewire microfilter.THE WOODLANDS, Texas--(BW HealthWire)--March 10, 1997--American BioMed Inc. (NASDAQ/OTC BB:ABMI ABMI Autologous Bone Marrow Infusion ), Monday announced that is application for a patent filed Nov. 30, 1995 for its percutaneous filter for carotid carotid /ca·rot·id/ (kah-rot´id) pertaining to the carotid artery, the principal artery of the neck. ca·rot·id n. angioplasty has received a Notice of Allowance from the U.S. Patent and Trademark Office. The company expects the patent to be issued within six months and development to start immediately. Company President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. , Steven B. Rash, stated: "The company is very pleased to receive this patent as it represents the addition of another technology to our portfolio of minimally invasive surgery minimally invasive surgery Laparoscopic surgery, see there. See Laparoscopic cholecystectomy. products. This device should permit safe minimally invasive treatment of carotid disease and could prevent strokes in over 100,000 procedures performed annually in the U.S." Industry analysts estimate an annual market potential of $500-million. The U.S. market is estimated to be one-half of the worldwide market. The company is currently developing prototypes and anticipates a 1998 product launch. Dr. Samuel S. Ahn, the company's chief clinical investigator, stated: "This device is designed to prevent the 10% rate of stroke and transient ischemic attack Transient Ischemic Attack Definition A transient ischemic attack, or TIA, is often described as a mini-stroke. Unlike a stroke, however, the symptoms can disappear within a few minutes. (TIA (1) (Telecommunications Industry Association, Arlington, VA, www.tiaonline.org) A membership organization founded in 1988 that sets telecommunications standards worldwide. It was originally an EIA working group that was spun off and merged with the U.S. ) currently associated with carotid stenting and balloon angioplasty balloon angioplasty: see under angioplasty. . When available, this filter will be a valuable contribution to the field of endovascular surgery. Furthermore, this device has a yet unmeasured potential clinical application in other peripheral vessels and the coronary arteries." American BioMed Inc. utilizes state of the art technology to develop, manufacture and market minimally invasive medical, surgical and diagnostic devices which deliver unique advantages through advanced science. Over 26 patents cover its portfolio of technologies competing in an industry with a combined worldwide market estimated at over $10-billion annually. -0- NOTE TO EDITORS: In the Internet/email address noted in this news release, there is an "at" symbol between tewinc and aol.com. This symbol may not appear properly in some systems. CONTACT: Thomas E. Waite & Associates Inc. 407/324-1606, (Fax) 407/324-0664 Email: tewinc@aol.com |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion